Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIES: AGN-190584 for Pseudophakic Presbyopia
NCT05393089Phase 2Withdrawn
- Sponsor
- Allergan
- Start
- Jun 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pilocarpine in presbyopia, sponsored by Allergan. Planned start Jun 2022; status: withdrawn.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05393089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05393089.